Eligible clinical trials as topic. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases23

Neoplasms Breast Neoplasms Recurrence Disease Progression Stroke HIV Infections Lung Neoplasms Chronic Disease Pain Drug-Related Side Effects and Adverse Reactions Acute Disease Cardiovascular Diseases Myocardial Infarction Postoperative Complications Diabetes Mellitus, Type 2 Neoplasm Recurrence, Local Disease Models, Animal Prostatic Neoplasms Neoplasm Metastasis Colorectal Neoplasms Heart Failure Weight Loss Melanoma

Chemicals and Drugs30

Placebos Antineoplastic Agents Drugs, Investigational Biological Markers Antibodies, Monoclonal Drug Combinations Antibodies, Monoclonal, Humanized Anti-Bacterial Agents Anti-HIV Agents Cancer Vaccines Anticoagulants Paclitaxel Fluorouracil Anti-Inflammatory Agents Platelet Aggregation Inhibitors Antihypertensive Agents Cardiovascular Agents Cyclophosphamide Hydroxymethylglutaryl-CoA Reductase Inhibitors Angiogenesis Inhibitors Anti-Infective Agents, Local Hypoglycemic Agents Cisplatin Doxorubicin Immunosuppressive Agents Fibrinolytic Agents Recombinant Proteins Methotrexate Deoxycytidine Immunologic Factors

Analytical, Diagnostic and Therapeutic Techniques and Equipment100

Clinical Trials as Topic Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Treatment Outcome Clinical Trials, Phase I as Topic Research Design Controlled Clinical Trials as Topic Double-Blind Method Randomized Controlled Trials as Topic Patient Selection Multicenter Studies as Topic Clinical Trials, Phase IV as Topic Placebos Clinical Protocols Prospective Studies Follow-Up Studies Single-Blind Method Early Termination of Clinical Trials Drug Therapy, Combination Drug Administration Schedule Sample Size Pilot Projects Questionnaires Meta-Analysis as Topic Severity of Illness Index Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Endpoint Determination Risk Factors Administration, Oral Survival Analysis Reproducibility of Results Risk Assessment Data Interpretation, Statistical Prognosis Feasibility Studies Pain Measurement Interviews as Topic Survival Rate Disease-Free Survival Drug Evaluation Drug Approval Cross-Over Studies Exercise Therapy Random Allocation Therapeutic Human Experimentation Infusions, Intravenous Phytotherapy Retrospective Studies Data Collection Analysis of Variance Chemotherapy, Adjuvant Drug Evaluation, Preclinical Statistics as Topic Predictive Value of Tests Treatment Failure Kaplan-Meier Estimate Immunotherapy Pragmatic Clinical Trials as Topic Cohort Studies Program Evaluation Statistics, Nonparametric Molecular Targeted Therapy Neoplasm Staging Sensitivity and Specificity Models, Statistical Incidence Genetic Therapy Human Experimentation Evaluation Studies as Topic Chi-Square Distribution Multivariate Analysis Proportional Hazards Models Administration, Topical Drug Therapy Pain Management Control Groups Magnetic Resonance Imaging Disease Models, Animal Regression Analysis Physical Therapy Modalities Individualized Medicine Drug Delivery Systems Drug Discovery Self Care Probability Chemoprevention Risk Therapy, Computer-Assisted Remission Induction Disability Evaluation Drug Design Quality-Adjusted Life Years Longitudinal Studies Models, Biological Logistic Models Linear Models Cluster Analysis Odds Ratio Therapies, Investigational

Psychiatry and Psychology17

Patient Compliance Cognitive Therapy Pain Health Knowledge, Attitudes, Practice Decision Making Counseling Communication Motivation Behavior Therapy Risk Reduction Behavior Smoking Cessation Attitude of Health Personnel Disclosure Physician-Patient Relations Cooperative Behavior Psychiatric Status Rating Scales Comprehension

Phenomena and Processes13

Time Factors Dose-Response Relationship, Drug Pain Pregnancy Sensitivity and Specificity Algorithms Recovery of Function Chi-Square Distribution Exercise Probability Risk Weight Loss Odds Ratio

Disciplines and Occupations14

Research Design Evidence-Based Medicine Biomedical Research Outcome Assessment (Health Care)Medical Oncology Therapeutic Human Experimentation Research Statistics as Topic Translational Medical Research Human Experimentation Comparative Effectiveness Research Individualized Medicine Drug Discovery Drug Design

Anthropology, Education, Sociology and Social Phenomena16

Quality of Life Patient Education as Topic Informed Consent United States Food and Drug Administration Drug Approval National Institutes of Health (U.S.)Programmed Instruction as Topic National Cancer Institute (U.S.)National Institute on Drug Abuse (U.S.)International Cooperation Internationality Health Education Curriculum Exercise Disclosure Forecasting

Technology, Industry, Agriculture3

Dietary Supplements Drug Industry Quality Control

Humanities7

Quality of Life Ethics Committees, Research Ethics, Medical Conflict of Interest Ethics, Research Therapeutic Equipoise History, 20th Century

Information Science29

Periodicals as Topic Review Literature as Topic Questionnaires Abstracting and Indexing as Topic Textbooks as Topic Data Interpretation, Statistical Terminology as Topic Publishing Interviews as Topic Survival Rate Internet Data Collection Herbals as Topic Publication Bias Communication Algorithms Incidence Databases as Topic Bookplates as Topic Broadsides as Topic Databases, Factual MEDLINE Bibliometrics Disclosure Webcasts as Topic Therapy, Computer-Assisted Quality-Adjusted Life Years Manuscripts as Topic Databases, Bibliographic

Named Groups4

Research Subjects Patient Dropouts Research Personnel Infant, Newborn

Health Care99

Clinical Trials as Topic Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Treatment Outcome Clinical Trials, Phase I as Topic Controlled Clinical Trials as Topic Double-Blind Method Randomized Controlled Trials as Topic Patient Selection Multicenter Studies as Topic Clinical Trials, Phase IV as Topic Clinical Trials Data Monitoring Committees Clinical Protocols Prospective Studies Follow-Up Studies Single-Blind Method Early Termination of Clinical Trials Congresses as Topic Sample Size Pilot Projects Guidelines as Topic Questionnaires Outcome Assessment (Health Care)Meta-Analysis as Topic Patient Education as Topic Cost-Benefit Analysis Severity of Illness Index Practice Guidelines as Topic Risk Factors Informed Consent Survival Analysis Reproducibility of Results Research Support as Topic Risk Assessment Patient Compliance Placebo Effect Patient Participation Data Interpretation, Statistical Feasibility Studies Benchmarking Interviews as Topic Survival Rate Disease-Free Survival United States Food and Drug Administration Cross-Over Studies Random Allocation Patient Satisfaction Intention to Treat Analysis National Institutes of Health (U.S.)Bias (Epidemiology)Retrospective Studies Data Collection Analysis of Variance National Cancer Institute (U.S.)Societies, Medical Statistics as Topic Predictive Value of Tests Treatment Failure Health Knowledge, Attitudes, Practice Kaplan-Meier Estimate Age Factors Safety Counseling Pragmatic Clinical Trials as Topic Cohort Studies Program Evaluation Statistics, Nonparametric Sensitivity and Specificity Ethics Committees, Research Models, Statistical Incidence Ethics, Medical Evaluation Studies as Topic Conflict of Interest National Institute on Drug Abuse (U.S.)Ethics, Research Chi-Square Distribution Multivariate Analysis Proportional Hazards Models Comparative Effectiveness Research Health Education Pain Management Health Promotion Regression Analysis Health Care Costs Attitude of Health Personnel Primary Health Care Selection Bias Self Care Probability Risk Quality-Adjusted Life Years Physician-Patient Relations Longitudinal Studies Cancer Care Facilities Logistic Models Linear Models Cluster Analysis Odds Ratio

Geographicals7

United States Great Britain Europe Canada Australia Netherlands Germany

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Clinical Trials as Topic Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Treatment Outcome Clinical Trials, Phase I as Topic Research Design Controlled Clinical Trials as Topic Double-Blind Method Randomized Controlled Trials as Topic Patient Selection Multicenter Studies as Topic Time Factors Clinical Trials, Phase IV as Topic Placebos Clinical Trials Data Monitoring Committees Neoplasms Clinical Protocols Prospective Studies Evidence-Based Medicine Follow-Up Studies Single-Blind Method Periodicals as Topic Antineoplastic Agents Early Termination of Clinical Trials Congresses as Topic United States Drug Therapy, Combination Drug Administration Schedule Sample Size Pilot Projects Quality of Life Review Literature as Topic Guidelines as Topic Research Subjects Biomedical Research Questionnaires Outcome Assessment (Health Care)Meta-Analysis as Topic Patient Education as Topic Cost-Benefit Analysis Abstracting and Indexing as Topic Severity of Illness Index Practice Guidelines as Topic Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Endpoint Determination Risk Factors Dose-Response Relationship, Drug Informed Consent Textbooks as Topic Administration, Oral Survival Analysis Reproducibility of Results Research Support as Topic Risk Assessment Patient Compliance Medical Oncology Breast Neoplasms Drugs, Investigational Placebo Effect Patient Participation Recurrence Data Interpretation, Statistical Prognosis Terminology as Topic Feasibility Studies Dietary Supplements Disease Progression Publishing Pain Measurement Drug Industry Benchmarking Interviews as Topic Survival Rate Disease-Free Survival United States Food and Drug Administration Drug Evaluation Drug Approval Stroke Cross-Over Studies HIV Infections Exercise Therapy Random Allocation Patient Satisfaction Therapeutic Human Experimentation Intention to Treat Analysis Internet Cognitive Therapy Biological Markers Antibodies, Monoclonal Drug Combinations Infusions, Intravenous National Institutes of Health (U.S.)Lung Neoplasms Phytotherapy Bias (Epidemiology)Retrospective Studies Patient Dropouts Programmed Instruction as Topic Data Collection

No FAQ available that match "eligible clinical trials as topic"